Boule Diagnostics
Boule Diagnostics AB is a global diagnostics company specializing in near-patient, decentralized blood diagnostics. The company is unique in the diagnostics market for conducting its own development, manufacturing, and marketing of instruments and consumables for blood diagnostics. Boule primarily serves hospitals, clinics, laboratories, and other diagnostics companies, offering complete systems for hematology in both human and veterinary areas. With strong positions in emerging markets like Asia, Boule has been expanding its presence in the fast-growing veterinary market.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueIncludes hematology analyzers and consumables for human blood diagnostics.
Instruments and consumables for veterinary blood diagnostics.
Contract development and manufacturing of reagents and blood controls.
Includes calibration and quality control products for diagnostics.
Customers
Boule Diagnostics serves a diverse range of customers, including hospitals, clinics, laboratories, and other diagnostics companies. These customers rely on Boule for complete blood diagnostics systems that offer reliability and accuracy. The company's products are particularly valued in emerging markets where access to decentralized diagnostics is crucial. Boule's veterinary diagnostics solutions also cater to the growing demand in the animal healthcare sector. The company's focus on OEM solutions attracts other diagnostics companies seeking high-quality reagents and blood controls.
Purchase hematology analyzers and consumables for patient diagnostics.
Use veterinary diagnostics instruments for animal health.
Contract for reagents and blood controls manufacturing.
Strategy
Boule Diagnostics is focused on expanding its installed base of instruments and enhancing its multi-brand strategy. The company is transitioning to strategic partnerships to access cutting-edge technologies, aiming to bring competitive products to market faster. Boule is also sharpening its focus on the OEM market for reagents and blood controls, which presents significant growth opportunities. The company is committed to operational improvements to stabilize profitability and deliver value to shareholders.
To increase market penetration and recurring revenue from consumables.
To accelerate access to new technologies and broaden product portfolio.
To capture growth opportunities in reagents and blood controls.
Geography
Q3/2025Boule Diagnostics operates globally with subsidiaries in Sweden, the United States, Mexico, and Russia. The company has a strong presence in emerging markets, particularly in Asia, where demand for decentralized diagnostics is growing. Boule's products are distributed in over 100 countries through a network of distributors, supported by local sales and service teams. This extensive geographic reach allows Boule to tap into diverse markets, mitigating risks associated with regional economic fluctuations.
Risks
Boule Diagnostics faces several risks, including currency fluctuations, particularly the impact of a weaker US dollar on revenues. The company is also exposed to risks from delayed customer payments and inventory adjustments by distributors. Additionally, the diagnostics industry is subject to regulatory changes and competitive pressures, which could affect market dynamics. Boule's reliance on emerging markets introduces geopolitical and economic risks that could impact operations.
- Currency FluctuationsImpact: HighLikelihood: High
Weaker USD impacts revenue and profitability.
- Regulatory ChangesImpact: HighLikelihood: Medium
Could alter market access and compliance costs.
- Delayed PaymentsImpact: Medium
Affects cash flow and delivery schedules.
Accounting
Judgemental itemsTiming affects quarterly results due to currency and payment delays.
Amortization and write-downs impact net income.
Affects reported liabilities and assets.
Similar listed companies
Publicly listed companies with a comparable business focus.
Getinge
GETI-B · Health Care
Getinge AB is a global provider of products and solutions for healthcare and life sciences, focusing on intensive care, cardiovascular procedures, operating…
Thule Group
THULE · Consumer Discretionary
Thule Group is a global company specializing in sports and outdoor products designed to simplify active lifestyles.
VolitionRX Limited
VNRX · In Vitro & In Vivo Diagnostic Substances
VolitionRx Ltd is a U.S.-based epigenetics diagnostics company developing blood-based tests that use nucleosomes and related biomarkers to detect and monitor disease.
Fulgent Genetics, Inc.
FLGT · Services-Medical Laboratories
IDEXX Laboratories, Inc
IDXX · In Vitro & In Vivo Diagnostic Substances
IDEXX Laboratories develops and sells diagnostic products and services for veterinarians, livestock producers, water testing customers, and selected human point-of-care uses.
QuidelOrtho Corp
QDEL · In Vitro & In Vivo Diagnostic Substances
QuidelOrtho Corp develops and markets diagnostic testing products used to detect, monitor, and help manage disease across clinical and decentralized care settings.
Last updated: 24/09/2026